CDC Report on COVID-19 Impact on Antibiotic Resistance

7/12/22 — The U.S. lost progress combating antimicrobial resistance (AR) in 2020 due, in large part, to effects of the COVID-19 pandemic, according to the newly released CDC report “COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022.” CDC’s 2019 AR Threats Report showed deaths from AR infections had decreased by 18 percent from 2012 through 2017. However, the 2021 analysis showed that resistant hospital-onset infections and deaths had increased at lest 15 percent from 2019 to 2020. Read more.